Risk of transferring malignant cells with transplanted frozen-thawed ovarian tissue
Marie‐Madeleine Dolmans(Cliniques Universitaires Saint-Luc), T. Grève(Copenhagen University Hospital), Jacques Donnez(European Society of Intensive Care Medicine), Claus Yding Andersen(Copenhagen University Hospital), Valérie A. Luyckx(UCLouvain)
Cited by 335
Related Papers
Livebirth after orthotopic transplantation of cryopreserved ovarian tissue
|The Lancet|2004|1.6k
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|921
The global burden of kidney disease and the sustainable development goals
|Bulletin of the World Health Organization|2018|917
Fertility Preservation in Women
|New England Journal of Medicine|2017|839
Uterine fibroid management: from the present to the future
|Human Reproduction Update|2016|750